| Temporomandibular joint disorders References |
|
[1]
Beers M, Berkow R. The Merck
Manual, 17th Ed. 1999. Chapter
108: Temporomandibular Disorders;
pp: 772-776.
[2]
Beers M, Berkow R. The Merck
Manual, 17th Ed. 1999. Chapter
108: Temporomandibular Disorders;
pp: 772-776.
[3]
www.nih.gov The National Institute
of Health. December 2004.
[4]
Beers M, Berkow R. The Merck
Manual, 17th Ed. 1999. Chapter
108: Temporomandibular Disorders;
pp: 772-776.
[5]
Shankland WE 2nd. The effects of
glucosamine and chondroitin
sulphate on osteoarthritis of the
temporomandibular joint: a
preliminary report of 50
patients. Cranio. 1998 Oct;
16(4): 230-235.
[6]
Najm WI, Reinsch S, Hoehler F,
Tobis JS, Harvey PW. S-adenosylmethionine
versus celecoxib for the treatment
of osteoarthritis symptoms: a
double blind crossover trial. BMC
Musculoskelet Disord. 2004 Feb
26; 5(1): 6.
[7]
Soeken KL, Lee WL, Bausell RB,
Agelli M, Berman BM. Safety and
efficacy of s-adenosylmethionine
for osteoarthritis. J Fam Pract.
2002 May; 51(5): 425-430.
[8]
Pizzorno J, Murray M, Joiner-Bey
H. The Clinicians Handbook of
Natural Medicine. 2002; Churchill
Livingstone New York.
Osteoarthritis: 364-371.
[9]
Machtey I, Ouknine L. Tocopherol
in osteoarthritis: a controlled
pilot study. J Am Geriatr Soc.
1978; 26: 328-330.
[10]
Scherak O et al. High dose
vitamin E therapy in patients with
activated arthritis. Z Rheumatol.
1990; 49: 369-373.
[11]
Sowers M, Lachance L. Vitamins
and arthritis: The roles of
Vitamins A, C, D and E. Rheum Dis
Clin North Am. 1999 May; 25(2):
315-332.
[12]
Kimmatkar N et al. Efficacy and
tolerability of boswellia serrata
extract in treatment of
osteoarthritis of the knee: a
randomized double blind placebo
controlled trial. Phytomedicine
2003 Jan; 10(1): 3-7.
[13]
Mills S, Bone K. Principles and
Practice of Phytotherapy.
Churchill Livingstone London;
2000. page 456.
|